ID   VMM1
AC   CVCL_A732
DR   ATCC; CRL-3225
DR   GEO; GSM1572805
DR   GEO; GSM1572806
DR   GEO; GSM1572807
DR   GEO; GSM1572808
DR   GEO; GSM1572809
DR   GEO; GSM1572810
DR   Wikidata; Q54993224
RX   PubMed=7681084;
RX   PubMed=10752474;
RX   PubMed=14871852;
RX   PubMed=20856146;
RX   PubMed=21654344;
CC   Population: Caucasian.
CC   HLA typing: A*03,26; B*51 (PubMed=10752474).
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): ATCC=CRL-3225
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9,11
ST   D16S539: 10
ST   D5S818: 9
ST   D7S820: 9,12
ST   TH01: 10
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 16
//
RX   PubMed=7681084; DOI=10.4049/jimmunol.150.7.2955;
RA   Slingluff C.L. Jr., Cox A.L., Henderson R.A., Hunt D.F.,
RA   Engelhard V.H.;
RT   "Recognition of human melanoma cells by HLA-A2.1-restricted cytotoxic
RT   T lymphocytes is mediated by at least six shared peptide epitopes.";
RL   J. Immunol. 150:2955-2963(1993).
//
RX   PubMed=10752474; DOI=10.1007/s002620050015; PMCID=PMC11037162;
RA   Slingluff C.L. Jr., Colella T.A., Thompson L., Graham D.D.,
RA   Skipper J.C.A., Caldwell J., Brinckerhoff L., Kittlesen D.J.,
RA   Deacon D.H., Oei C., Harthun N.L., Huczko E.L., Hunt D.F.,
RA   Darrow T.L., Engelhard V.H.;
RT   "Melanomas with concordant loss of multiple melanocytic
RT   differentiation proteins: immune escape that may be overcome by
RT   targeting unique or undefined antigens.";
RL   Cancer Immunol. Immunother. 48:661-672(2000).
//
RX   PubMed=14871852; DOI=10.1158/0008-5472.CAN-03-2209;
RA   Hogan K.T., Coppola M.A., Gatlin C.L., Thompson L.W., Shabanowitz J.,
RA   Hunt D.F., Engelhard V.H., Ross M.M., Slingluff C.L. Jr.;
RT   "Identification of novel and widely expressed cancer/testis gene
RT   isoforms that elicit spontaneous cytotoxic T-lymphocyte reactivity to
RT   melanoma.";
RL   Cancer Res. 64:1157-1163(2004).
//
RX   PubMed=20856146; DOI=10.1097/CMR.0b013e32833fafb4; PMCID=PMC3229868;
RA   Mikesh L.M., Kumar M., Erdag G., Hogan K.T., Molhoek K.R., Mayo M.W.,
RA   Slingluff C.L. Jr.;
RT   "Evaluation of molecular markers of mesenchymal phenotype in
RT   melanoma.";
RL   Melanoma Res. 20:485-495(2010).
//
RX   PubMed=21654344; DOI=10.1097/CMR.0b013e328343a1d6; PMCID=PMC3131461;
RA   Molhoek K.R., Shada A.L., Smolkin M., Chowbina S., Papin J.,
RA   Brautigan D.L., Slingluff C.L. Jr.;
RT   "Comprehensive analysis of receptor tyrosine kinase activation in
RT   human melanomas reveals autocrine signaling through IGF-1R.";
RL   Melanoma Res. 21:274-284(2011).
//